GlaxoSmithKline S.A.E (EGX:BIOC)

Egypt flag Egypt · Delayed Price · Currency is EGP
38.13
+0.06 (0.16%)
At close: Jun 25, 2025
38.45%
Market Cap 3.06B
Revenue (ttm) 3.27B
Net Income (ttm) 242.09M
Shares Out 83.51M
EPS (ttm) 2.90
PE Ratio 12.65
Forward PE n/a
Dividend 0.75 (2.02%)
Ex-Dividend Date Jul 18, 2024
Volume 32,437
Average Volume 85,343
Open 38.07
Previous Close 38.07
Day's Range 37.69 - 38.88
52-Week Range 24.70 - 47.30
Beta 0.93
RSI 37.85
Earnings Date Aug 14, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited. [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 800
Stock Exchange Egyptian Stock Exchange
Ticker Symbol BIOC
Full Company Profile

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.

Financial Statements

News

There is no news available yet.